PLN 2.37
(-1.25%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 2019.00 PLN | -98.55% |
2022 | 139.54 Thousand PLN | -71.66% |
2021 | 492.49 Thousand PLN | -28.37% |
2020 | 687.5 Thousand PLN | 95.41% |
2019 | 351.83 Thousand PLN | 219.01% |
2018 | 110.28 Thousand PLN | 170.33% |
2017 | 40.79 Thousand PLN | 0.0% |
2016 | - PLN | -100.0% |
2015 | 7403.00 PLN | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - PLN | -100.0% |
2024 Q1 | 2000.00 PLN | 128.65% |
2023 Q3 | 6000.00 PLN | 123.08% |
2023 Q1 | 29 Thousand PLN | 189.74% |
2023 Q2 | -26 Thousand PLN | -189.66% |
2023 FY | 2019.00 PLN | -98.55% |
2023 Q4 | -6981.00 PLN | -216.35% |
2022 Q2 | 16.68 Thousand PLN | -62.51% |
2022 FY | 139.54 Thousand PLN | -71.66% |
2022 Q4 | -32.31 Thousand PLN | -129.2% |
2022 Q3 | 110.68 Thousand PLN | 563.4% |
2022 Q1 | 44.5 Thousand PLN | -89.25% |
2021 Q1 | 4822.00 PLN | -98.61% |
2021 Q2 | 78.09 Thousand PLN | 1519.64% |
2021 FY | 492.49 Thousand PLN | -28.37% |
2021 Q3 | -4219.53 PLN | -105.4% |
2021 Q4 | 413.78 Thousand PLN | 9906.52% |
2020 Q2 | 136 Thousand PLN | 8966.67% |
2020 Q1 | 1500.00 PLN | 100.81% |
2020 FY | 687.5 Thousand PLN | 95.41% |
2020 Q4 | 346 Thousand PLN | 69.61% |
2020 Q3 | 204 Thousand PLN | 50.0% |
2019 Q2 | 6030.00 PLN | -97.15% |
2019 Q1 | 211.5 Thousand PLN | 2572.12% |
2019 FY | 351.83 Thousand PLN | 219.01% |
2019 Q3 | 319 Thousand PLN | 5190.28% |
2019 Q4 | -184.7 Thousand PLN | -157.9% |
2018 Q2 | 46.96 Thousand PLN | 1005.93% |
2018 Q3 | 67.63 Thousand PLN | 43.99% |
2018 FY | 110.28 Thousand PLN | 170.33% |
2018 Q4 | -8555.42 PLN | -112.65% |
2018 Q1 | 4246.82 PLN | 663.82% |
2017 Q2 | 48.2 Thousand PLN | 19.8% |
2017 FY | 40.79 Thousand PLN | 0.0% |
2017 Q3 | 0.28 PLN | -100.0% |
2017 Q1 | 40.24 Thousand PLN | 0.0% |
2017 Q4 | 556.00 PLN | 198471.43% |
2016 FY | - PLN | -100.0% |
2015 FY | 7403.00 PLN | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Bioceltix S.A. | - PLN | -Infinity% |
BIOTON S.A. | 181.63 Million PLN | 99.999% |
Captor Therapeutics Spolka Akcyjna | 13.2 Million PLN | 99.985% |
Mabion S.A. | 151.67 Million PLN | 99.999% |
Molecure S.A. | 100.00 PLN | -1919.0% |
Pharmena S.A. | 9.83 Million PLN | 99.979% |
Poltreg S.A. | 1.39 Million PLN | 99.856% |
Pure Biologics Spólka Akcyjna | 95 Thousand PLN | 97.875% |
Ryvu Therapeutics S.A. | 46.86 Million PLN | 99.996% |
Synthaverse S.A. | 58.6 Million PLN | 99.997% |
Urteste S.A. | - PLN | -Infinity% |